Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

LABORIE Medical Technologies Announces Completion of Clinical Innovations Acquisition

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Johnson & Johnson to Acquire Atraverse...

Johnson & Johnson has entered into a definitive agreement...

US Speeds Insurance Coverage for Breakthrough...

A new federal initiative in the United States is...

FDA Flags Nitrosamine Impurity Risk in...

The U.S. Food and Drug Administration (FDA), through its...

LABORIE Medical Technologies, a leading diagnostic and therapeutic medical technology company, announced it has completed its acquisition of Clinical Innovations for an enterprise value of $525 million.

Based in Salt Lake City, Clinical Innovations is a leading global provider of clinician-preferred medical devices for the labor & delivery (L&D) and neonatal intensive care unit (NICU) specialties.

โ€œWe are pleased to welcome the incredibly talented Clinical Innovations team to the LABORIE family,โ€ commented Michael Frazzette, President & CEO of LABORIE Medical Technologies. โ€œWe look forward to investing in, and building upon Clinical Innovationsโ€™ unique product portfolio and specialty channels to continue to benefit mothers, babies and healthcare professionals around the world.โ€

In order to drive the focus, resources, investments and customer-intense culture needed to continue to be successful in the L&D and NICU specialties, the Clinical Innovations business will form a stand-alone Global Business Unit (GBU) called Maternal and Child Health.

โ€œThis focused GBU approach will enable us to build on Clinical Innovationsโ€™ established strong and trusted relationships with physicians and nurses; and serve the distinct customer call point of obstetricians, gynecologists, neonatologists, and NICU and L&D nurses,โ€ Frazzette added.

โ€œWe look forward to leveraging Patricia Industriesโ€™ healthcare expertise and global presence to support the combined LABORIE and Clinical Innovations organization as we embark on our next phase of growth together,” said Yuriy Prilutskiy, Managing Director at Patricia Industries, a part of Investor AB, and owner of LABORIE Medical Technologies. โ€œConsistent with our purpose of creating value for people and society by building strong and sustainable businesses, we will continue to invest in and develop the company to improve clinical outcomes for patients around the world for many years to come.โ€

Piper Jaffray acted as financial advisor and Cleary Gottlieb Steen & Hamilton LLP as legal advisor to LABORIE.

MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Johnson & Johnson to Acquire Atraverse Medical Platform

Johnson & Johnson has entered into a definitive agreement...

US Speeds Insurance Coverage for Breakthrough Medical Device

A new federal initiative in the United States is...

FDA Flags Nitrosamine Impurity Risk in Combination Products

The U.S. Food and Drug Administration (FDA), through its...

FDA 510(k) Clearance Granted to Philips Rembra Platform

Philips has secured FDA 510(k) clearance for its Rembra...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป